HEATHER PARKERSON: Open Payments
NPI 1467901025 · EVANSTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,249 in 84 payments from 11 companies in 2025. Trend: 2023 $1,976 · 2024 $1,646 · 2025 $1,249
Food & beverage: $1,249
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $410 |
| ABBVIE INC. | 28 | $169 |
| Axsome Therapeutics, Inc. | 11 | $165 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $112 |
| Noven Therapeutics, LLC | 4 | $91 |
| Lundbeck LLC | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Tris Pharma Inc | 3 | $57 |
| E.R. Squibb & Sons, L.L.C. | 2 | $57 |
| Janssen Pharmaceuticals, Inc | 1 | $33 |
Products named: CAPLYTA, VRAYLAR, REXULTI, TRINTELLIX, Auvelity, Xelstrym, Sunosi, Dyanavel XR.
Industry payments across IL — which companies pay providers there.
